Medindia
Medindia LOGIN REGISTER
Advertisement

ScienceBased Health Announces the Launch of Diavis(TM), a New Dietary Supplement for the 81 Million Americans With or at Risk for Diabetes

Monday, November 10, 2008 General News
Advertisement
ATLANTA, Nov. 10 The American Academy of Ophthalmology(AAO) 2008 Annual Meeting -- ScienceBased Health, a leading provider ofpremium nutraceuticals for eye health, today announced the launch of DiaVis, aspecialized dietary supplement to support the visual and overall health ofthose with diabetes.
Advertisement

24 million Americans -- 8% of the population and nearly 25% of those 60and older -- currently suffer from diabetes. When added to the 57 millionAmericans with pre-diabetes, an astounding 81 million Americans either havethe condition or are considered at risk according to 2007 prevalence data fromthe CDC. Pre-diabetes, characterized by elevated blood sugar levels, is aprecursor of adult-onset diabetes.
Advertisement

Diabetes is a disease in which the body does not produce or properly useinsulin. As a result, blood glucose levels become too high. Those withdiabetes are at an increased risk for developing a number of complications,such as heart disease, stroke and retinopathy. Retinopathy, estimated toaffect up to 80% of those with diabetes over time, is the most common diabeticeye disease and a leading cause of blindness.

Research has identified nutrients that may be low in diabetics due toinadequate nutrient intake, increased excretion, and altered nutrientrequirements due to higher oxidative stress or use of diabetes-relatedmedications. Some studies have found diabetics and those with retinopathy tobe low in antioxidants. Antioxidants have been found to play an important rolein helping to combat oxidative stress, which plays a role in developingdiabetic complications.

DiaVis delivers a blend of key antioxidants, including Pycnogenol(R), andother nutrients found to play a role in helping to combat oxidative stress andinflammation, and that tend to be marginally low in those with diabetes.Additionally, DiaVis delivers ingredients found to play a role in normalglucose metabolism and retinal vessel health.

"DiaVis was developed for those with diabetes as well as the overwhelmingnumber of people with pre-diabetes, said Alain Magro, president, ScienceBasedHealth. "Research shows that damage to the body is already occurring in thepre-diabetes phase and that certain nutrients can play a crucial role inbolstering the body's defenses. We believe that DiaVis represents the mostadvanced scientific research on the role of nutrition in diabetic health."

DiaVis is now available through eyecare practitioners or ScienceBasedHealth: 888.433.4726; http;//www.sciencebasedhealth.com. DiaVis retails for$34.95 (30 day supply).

About ScienceBased Health

ScienceBased Health, a privately held company, develops and marketsevidence-based nutraceuticals for eye health. The formulations, created byleading physicians, nutrition scientists and researchers, are based on thelatest scientific research and are recommended by several thousandophthalmologists and optometrists nationwide. The Company developedHydroEye(R), a patented, oral formulation for dry eyes; OcularProtect(R), acomprehensive multinutrient for eyes and overall body health; MacularProtectComplete(R) and MacularProtect Complete(R)-S, powerful formulations, based onAREDS and other advanced research, to preserve macular and whole body health;Optic Nerve Formula(R), a powerful formulation to protect optic nerve health;DiaVis(TM), a targeted formulation for those with diabetes and at risk fordiabetes; and other high quality products for eye and body health. Theproducts are made from premium ingredients and manufactured according tohighest quality standards. For more information, contact ScienceBased Healthat: (888) 433-4726 or visit: http://www.sciencebasedhealth.com.

SOURCE ScienceBased Health
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close